» Articles » PMID: 38753874

Liebig's Law of the Minimum in the TGF-β/SMAD Pathway

Overview
Specialty Biology
Date 2024 May 16
PMID 38753874
Authors
Affiliations
Soon will be listed here.
Abstract

Cells use signaling pathways to sense and respond to their environments. The transforming growth factor-β (TGF-β) pathway produces context-specific responses. Here, we combined modeling and experimental analysis to study the dependence of the output of the TGF-β pathway on the abundance of signaling molecules in the pathway. We showed that the TGF-β pathway processes the variation of TGF-β receptor abundance using Liebig's law of the minimum, meaning that the output-modifying factor is the signaling protein that is most limited, to determine signaling responses across cell types and in single cells. We found that the abundance of either the type I (TGFBR1) or type II (TGFBR2) TGF-β receptor determined the responses of cancer cell lines, such that the receptor with relatively low abundance dictates the response. Furthermore, nuclear SMAD2 signaling correlated with the abundance of TGF-β receptor in single cells depending on the relative expression levels of TGFBR1 and TGFBR2. A similar control principle could govern the heterogeneity of signaling responses in other signaling pathways.

References
1.
Mattiazzi Usaj M, Yeung C, Friesen H, Boone C, Andrews B . Single-cell image analysis to explore cell-to-cell heterogeneity in isogenic populations. Cell Syst. 2021; 12(6):608-621. PMC: 9112900. DOI: 10.1016/j.cels.2021.05.010. View

2.
Fleming N, Jorissen R, Mouradov D, Christie M, Sakthianandeswaren A, Palmieri M . SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Res. 2012; 73(2):725-35. DOI: 10.1158/0008-5472.CAN-12-2706. View

3.
Hill C . Nucleocytoplasmic shuttling of Smad proteins. Cell Res. 2008; 19(1):36-46. DOI: 10.1038/cr.2008.325. View

4.
Cohen-Saidon C, Cohen A, Sigal A, Liron Y, Alon U . Dynamics and variability of ERK2 response to EGF in individual living cells. Mol Cell. 2009; 36(5):885-93. DOI: 10.1016/j.molcel.2009.11.025. View

5.
Ijichi H, Chytil A, Gorska A, Aakre M, Fujitani Y, Fujitani S . Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev. 2006; 20(22):3147-60. PMC: 1635149. DOI: 10.1101/gad.1475506. View